EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Astragaloside IV Ameliorates Cerebral Ischemic-Reperfusion Injury via Improving Mitochondrial Function and Inhibiting Neuronal Apoptosis

Tongtong He iD, Xiaohong Zhou, Xiaorong Wang, Yanmeng Zhao, Zhenyi Liu, Ping Gao, Weijuan Gao, Xiaofei Jin

Current Issues in Molecular Biology · 29.07.2025 · 47 (8) · 597

DOI: 10.3390/cimb47080597 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Current Issues in Molecular Biology, online erschienen am 29.07.2025. Verfasst von Tongtong He und 7 weiteren Autor:innen. Beteiligte Einrichtung: Hebei Key Laboratory of Chinese Medicine Research on Cardio-Cerebrovascular Disease, Hebei University of Chinese Medicine, No. 3 Xingyuan Road, Luqua…. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Hebei Province Natural Science Foundation Project, Hebei Province Administration of Traditional Chinese Medicine Research Plan Project, Hebei Province Graduate Innovation Support Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cerebral ischemic-reperfusion injury (CIRI) involves mitochondrial dysfunction, with mitophagy playing a key role. Astragaloside IV (AS-IV) shows neuroprotective potential; however, its mechanisms related to mitochondrial function and apoptosis remain unclear.

Methods

Using a rat MCAO/R model, we evaluated the AS-IV’s effects via neurological scores, TTC staining, and histopathology. Molecular assays and docking were used to analyze mitophagy (PINK1, Parkin, p62, ROS, Bcl-2, and BAX) and apoptosis markers.

Results

AS-IV improved neurological function, reduced infarct volume, and alleviated neuronal/mitochondrial damage. It upregulated PINK1/Parkin, decreased p62, and modulated Bcl-2/Bax. Docking confirmed AS-IV binds PINK1/Parkin with high affinity.

Conclusions

AS-IV protects against CIRI by regulating the PINK1/Parkin pathway, improving mitochondrial function, and inhibiting neuronal apoptosis, providing an experimental basis for the clinical use

Schlagwörter

Stichwörter der Autor:innen

PINK1/Parkin pathwayastragaloside IVcerebral ischemic reperfusion injuryreactive oxygen species

Autor:innen und Institutionen

  • Hebei Key Laboratory of Chinese Medicine Research on Cardio-Cerebrovascular Disease, Hebei University of Chinese Medicine, No. 3 Xingyuan Road, Luquan District, Shijiazhuang 050200, China.

ORCID-Profile: Tongtong He

Förderung

  • Hebei Province Natural Science Foundation Project
  • Hebei Province Administration of Traditional Chinese Medicine Research Plan Project
  • Hebei Province Graduate Innovation Support Project
  • Hebei University of Chinese Medicine Yan Zhao Medical Research Project
  • Hebei University of Chinese Medicine Provincial Higher Education Basic Scientific Research Business Fee Special Project
  • Key Project of the Joint Fund for Innovation and Development of Traditional Chinese Medicine

Zitieren

APA

He, T., Zhou, X., Wang, X., Zhao, Y., Liu, Z., Gao, P., Gao, W., & Jin, X. (2025). Astragaloside IV Ameliorates Cerebral Ischemic-Reperfusion Injury via Improving Mitochondrial Function and Inhibiting Neuronal Apoptosis. Current Issues in Molecular Biology, 47(8), 597. https://doi.org/10.3390/cimb47080597

Vancouver

He T, Zhou X, Wang X, Zhao Y, Liu Z, Gao P, et al. Astragaloside IV Ameliorates Cerebral Ischemic-Reperfusion Injury via Improving Mitochondrial Function and Inhibiting Neuronal Apoptosis. Current Issues in Molecular Biology. 2025;47(8):597. doi:10.3390/cimb47080597

BibTeX
@article{He2025,
  author = {He, Tongtong and Zhou, Xiaohong and Wang, Xiaorong and Zhao, Yanmeng and Liu, Zhenyi and Gao, Ping and Gao, Weijuan and Jin, Xiaofei},
  title = {Astragaloside IV Ameliorates Cerebral Ischemic-Reperfusion Injury via Improving Mitochondrial Function and Inhibiting Neuronal Apoptosis},
  journal = {Current Issues in Molecular Biology},
  year = {2025},
  volume = {47},
  number = {8},
  pages = {597},
  doi = {10.3390/cimb47080597}
}
Kostenlos starten →